Yara van Holstein1, Floor J van Deudekom2, Stella Trompet2, Iris Postmus2, Anna Uit den Boogaard2, Marjan J T van der Elst2, Nienke A de Glas3, Diana van Heemst2, Geert Labots4, Mariëtte Altena5, Marije Slingerland3, Gerrit Jan Liefers6, Frederiek van den Bos2, Jessica M van der Bol7, Gerard J Blauw2, Johanneke E A Portielje3, Simon P Mooijaart2,8. 1. Department of Internal Medicine, Section of Gerontology and Geriatrics, Leiden University Medical Center, PO box 9600, 2300 RC, Leiden, The Netherlands. Y.van_Holstein@lumc.nl. 2. Department of Internal Medicine, Section of Gerontology and Geriatrics, Leiden University Medical Center, PO box 9600, 2300 RC, Leiden, The Netherlands. 3. Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands. 4. Department of Internal Medicine, Haga Hospital, The Hague, The Netherlands. 5. Department of Internal Medicine, Haaglanden Medical Center, The Hague, The Netherlands. 6. Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. 7. Department of Geriatrics, Reinier de Graaf Hospital, Delft, The Netherlands. 8. Institute for Evidence-based Medicine in Old Age (IEMO), Leiden, The Netherlands.
Abstract
BACKGROUND: Treatment decisions concerning older patients can be very challenging and individualised treatment plans are often required in this very heterogeneous group. In 2015 we have implemented a routine clinical care pathway for older patients in need of intensive treatment, including a comprehensive geriatric assessment (CGA) that was used to support clinical decision making. An ongoing prospective cohort study, the Triaging Elderly Needing Treatment (TENT) study, has also been initiated in 2016 for participants in this clinical care pathway, to study associations between geriatric characteristics and outcomes of treatment that are relevant to older patients. The aim of this paper is to describe the implementation and rationale of the routine clinical care pathway and design of the TENT study. METHODS: A routine clinical care pathway has been designed and implemented in multiple hospitals in the Netherlands. Patients aged ≥70 years who are candidates for intensive treatments, such as chemotherapy, (chemo-)radiation therapy or major surgery, undergo frailty screening based on the Geriatric 8 (G-8) questionnaire and the Six-Item Cognitive Impairment Test (6CIT). If screening reveals potential frailty, a CGA is performed. All patients are invited to participate in the TENT study. Clinical data and blood samples for biomarker studies are collected at baseline. During follow-up, information about treatment complications, hospitalisations, functional decline, quality of life and mortality is collected. The primary outcome is the composite endpoint of functional decline or mortality at 1 year. DISCUSSION: Implementation of a routine clinical care pathway for older patients in need of intensive treatment provides the opportunity to study associations between determinants of frailty and outcomes of treatment. Results of the TENT study will support individualised treatment for future patients. TRIAL REGISTRATION: The study is retrospectively registered at the Netherlands Trial Register (NTR), trial number NL8107 . Date of registration: 22-10-2019.
BACKGROUND: Treatment decisions concerning older patients can be very challenging and individualised treatment plans are often required in this very heterogeneous group. In 2015 we have implemented a routine clinical care pathway for older patients in need of intensive treatment, including a comprehensive geriatric assessment (CGA) that was used to support clinical decision making. An ongoing prospective cohort study, the Triaging Elderly Needing Treatment (TENT) study, has also been initiated in 2016 for participants in this clinical care pathway, to study associations between geriatric characteristics and outcomes of treatment that are relevant to older patients. The aim of this paper is to describe the implementation and rationale of the routine clinical care pathway and design of the TENT study. METHODS: A routine clinical care pathway has been designed and implemented in multiple hospitals in the Netherlands. Patients aged ≥70 years who are candidates for intensive treatments, such as chemotherapy, (chemo-)radiation therapy or major surgery, undergo frailty screening based on the Geriatric 8 (G-8) questionnaire and the Six-Item Cognitive Impairment Test (6CIT). If screening reveals potential frailty, a CGA is performed. All patients are invited to participate in the TENT study. Clinical data and blood samples for biomarker studies are collected at baseline. During follow-up, information about treatment complications, hospitalisations, functional decline, quality of life and mortality is collected. The primary outcome is the composite endpoint of functional decline or mortality at 1 year. DISCUSSION: Implementation of a routine clinical care pathway for older patients in need of intensive treatment provides the opportunity to study associations between determinants of frailty and outcomes of treatment. Results of the TENT study will support individualised treatment for future patients. TRIAL REGISTRATION: The study is retrospectively registered at the Netherlands Trial Register (NTR), trial number NL8107 . Date of registration: 22-10-2019.
Entities:
Keywords:
Aortic valve replacement; Colon cancer; Comprehensive geriatric assessment; Frailty; Geriatric oncology; Head and neck cancer; Oesophageal cancer; Older patients; Study protocol
Authors: Juliette L Parlevliet; Janet MacNeil-Vroomen; Bianca M Buurman; Sophia E de Rooij; Judith E Bosmans Journal: J Am Geriatr Soc Date: 2016-04 Impact factor: 5.562
Authors: J de Gelder; J A Lucke; L C Blomaard; A M Booijen; A J Fogteloo; S Anten; E W Steyerberg; J Alsma; S C E Klein Nagelvoort Schuit; A Brink; B de Groot; G J Blauw; S P Mooijaart Journal: Exp Gerontol Date: 2018-06-20 Impact factor: 4.032
Authors: Floor J van Deudekom; Iris Postmus; Danielle J van der Ham; Alexander B Pothof; Karen Broekhuizen; Gerard J Blauw; Simon P Mooijaart Journal: PLoS One Date: 2017-03-27 Impact factor: 3.240
Authors: Carlijn G N Voorend; Hanneke Joosten; Noeleen C Berkhout-Byrne; Adry Diepenbroek; Casper F M Franssen; Willem Jan W Bos; Marjolijn Van Buren; Simon P Mooijaart Journal: Eur Geriatr Med Date: 2021-04-19 Impact factor: 1.710